Literature DB >> 17053697

Three-year developmental outcomes in children with prenatal alcohol and drug exposure.

Deborah Kartin1, Therese M Grant, Ann P Streissguth, Paul D Sampson, Cara C Ernst.   

Abstract

PURPOSE: The purpose of this study was to describe the performance of children whose mothers abused alcohol and drugs heavily during pregnancy, using the Bayley Scales of Infant Development Second Edition (BSID-II) at three years, and to examine the effects of study group, prenatal binge alcohol exposure, and prematurity on developmental outcome.
METHODS: Children were born to mothers recruited from two large hospitals or through community referral. Hospital recruits were randomly assigned to either a three-year paraprofessional home visitation intervention program (n = 30) or a control group (n = 31). Community recruits were enrolled in the intervention program (n = 35).
RESULTS: Among all children the mean BSID-II Mental Developmental Index (MDI) was 84.4 (SD = 14.4) and mean Psychomotor Developmental Index (PDI) was 84.1 (SD = 16.9). Box plots of the MDI and PDI scores by study group, maternal prenatal binge alcohol status, and a binary indicator of prematurity suggested an effect of maternal binge drinking on MDI and PDI scores: children of mothers with a history of binge alcohol consumption have, on average, slightly lower scores. We saw no evidence of a systematic effect of the maternal intervention.
CONCLUSIONS: Developmental performance of preschool children exposed to alcohol and drugs prenatally was, on average, substantially lower than expected for age regardless of study group. Although this home visitation intervention has been shown to be effective in helping mothers address a wide spectrum of needs, it is unlikely sufficient to overcome complex developmental risks of children exposed to alcohol and drugs prenatally. The effect of more comprehensive, multidimensional services specifically designed for the children should be investigated within this context.

Entities:  

Year:  2002        PMID: 17053697     DOI: 10.1097/00001577-200214030-00004

Source DB:  PubMed          Journal:  Pediatr Phys Ther        ISSN: 0898-5669            Impact factor:   3.049


  7 in total

Review 1.  Lay health workers in primary and community health care for maternal and child health and the management of infectious diseases.

Authors:  Simon Lewin; Susan Munabi-Babigumira; Claire Glenton; Karen Daniels; Xavier Bosch-Capblanch; Brian E van Wyk; Jan Odgaard-Jensen; Marit Johansen; Godwin N Aja; Merrick Zwarenstein; Inger B Scheel
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

Review 2.  Interventions in fetal alcohol spectrum disorders: An international perspective.

Authors:  Christie L M Petrenko; Michelle E Alto
Journal:  Eur J Med Genet       Date:  2016-10-11       Impact factor: 2.708

Review 3.  Home visits during pregnancy and after birth for women with an alcohol or drug problem.

Authors:  Catherine Turnbull; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

4.  Disparities in the prevalence of cognitive delay: how early do they appear?

Authors:  Marianne M Hillemeier; George Farkas; Paul L Morgan; Molly A Martin; Steven A Maczuga
Journal:  Paediatr Perinat Epidemiol       Date:  2009-01-14       Impact factor: 3.980

5.  Gestational age at enrollment and continued substance use among pregnant women in drug treatment.

Authors:  Mishka Terplan; Joanne Garrett; Katherine Hartmann
Journal:  J Addict Dis       Date:  2009

6.  Still too little qualitative research to shed light on results from reviews of effectiveness trials: a case study of a Cochrane review on the use of lay health workers.

Authors:  Claire Glenton; Simon Lewin; Inger B Scheel
Journal:  Implement Sci       Date:  2011-05-27       Impact factor: 7.327

Review 7.  Effectiveness of home visiting programs on child outcomes: a systematic review.

Authors:  Shelley Peacock; Stephanie Konrad; Erin Watson; Darren Nickel; Nazeem Muhajarine
Journal:  BMC Public Health       Date:  2013-01-09       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.